HKSTP and AstraZeneca signing MOU on Strategic Collaboration
Hong Kong Science and Technology Parks (HKSTP) continues to strengthen the strategic partnership with AstraZeneca, one of the world's leading pharmaceutical companies. The goal of this collaboration is to position Hong Kong and the Greater Bay Area as a trailblazer in life science innovation and serve as a model for the region. This marks a milestone that HKSTP has entered into a multidimensional collaboration, which includes technology and data sharing, with a life science corporation.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230404005674/en/
Mr Albert Wong, CEO of Hong Kong Science and Technology Parks (left, front row) and Ms Shan Wu, General Manager, AstraZeneca Hong Kong and Macau (right, front row) signed the Co-incubation Programme. Witnessed by Dr Sunny Chai, BBS, JP, Chairman, Hong Kong Science and Technology Parks Corporation (2nd from left, 2nd row), Ms Lillian Cheong, JP, Under Secretary, Innovation, Technology and Industry Bureau (middle, 2nd row), Sir Pascal Soriot, Chief Executive of AstraZeneca (2nd from right, 2nd row), Mr Leon Wang, Executive Vice President, International and China President, AstraZeneca (right, 2nd row) and Dr Grace Lau, Head of Institute for Translational Research Hong Kong Science and Technology Parks Corporation (left, 2nd row).
Since 2021, AstraZeneca and HKSTP have been collaborating, and this partnership will not only continue but also be upgraded. The extended collaboration involves AstraZeneca and HKSTP supporting and providing services to startup companies under the HKSTP co-incubation programme. Additionally, the collaboration includes attracting more overseas and China mainland companies to the HKSTP community, with the aim of connecting them with hospitals, key opinion leaders in the Greater Bay Area, and universities in Hong Kong.
The 2022 Policy Address emphasised the city's commitment to fostering innovation and technology. AstraZeneca and HKSTP share the same aspiration to partner with the HKSAR government to improve the healthcare ecosystem in Hong Kong.
AstraZeneca will also provide consultation on setting up international offices in Hong Kong and support connecting overseas investors with HKSTP co-incubation programs. Besides, roadshow sessions at HKSTP will be held for overseas and China R&D Health Conferences to forge non-traditional partnerships across geographical boundaries, facilitating collaborative action and opening up new opportunities to enhance patient-enabled innovation.
The MOU was signed by Ms Shan Wu, General Manager of AstraZeneca Hong Kong and Macau, and Mr Albert Wong, Chief Executive Officer of HKSTP, at a ceremony witnessed by Sir Pascal Soriot, Chief Executive Officer of AstraZeneca, Mr Leon Wang, Executive Vice President, International and China President of AstraZeneca, and Dr Sunny Chai, Chairman of HKSTP.
Dr Sunny Chai, Chairman of HKSTP, expressed his delight in witnessing the collaboration between HKSTP and AstraZeneca in building a healthcare innovation ecosystem in Hong Kong. “Biotechnology is important not only to Hong Kong’s economic development but also humankind. Aligning with the Hong Kong Innovation and Technology Development Blueprint, HKSTP is fully committed to pioneering its success by welcoming talent, companies and investment globally to benefit from Hong Kong’s established track record in R&D, advanced manufacturing as well as commercialisation. This latest agreement is another major milestone in our partnership with AstraZeneca and further builds upon the positive momentum within HKSTP’s biotechnology ecosystem.”
Ms Lillian Cheong, Under Secretary for Innovation, Technology and Industry, said: “Promoting the development of I&T is of top priorities of the SAR Government. The National 14th Five-Year Plan also provides staunch support for Hong Kong's development as an international I&T hub. The SAR Government proposed to focus on industries with an edge including life and health technology, and formulate attractive special facilitation measures to attract prominent companies to set foot in Hong Kong or expand their existing businesses here. I am pleased to see the collaboration between AZHK and HKSTP which is not only a testament to Hong Kong’s great R&D capabilities in life and health technology, but also demonstrates the co-operation between the upstream and downstream sectors. I look forward to joining hands with all of you to fully seize the golden development opportunities ahead.”
Mr Leon Wang, Executive Vice President, International and China President of AstraZeneca, expressed his enthusiasm for the partnership between HKSTP and AstraZeneca. “As a global pharmaceutical leader with strong connections to business leaders, scientists, marketers, and investors around the world, AstraZeneca is well-equipped to help nurture more health talents and drive significant growth in Hong Kong's medical research, drug development, and clinical trial processes.”
Dr Grace Lau, Head of Institute for Translational Research, HKSTP, emphasised the importance of attracting more large multinationals to become co-incubators and establish research and development laboratories within the HKSTP ecosystem. Multinationals provide invaluable mentorship, sharing their resources and expertise with startups. HKSTP has already established partnerships with multinationals that operate innovation centres overseas, effectively extending their incubation program to other parts of the world. Additionally, they hope to draw more quality startups to Hong Kong with the help of these multinational partners.
About Hong Kong Science and Technology Parks Corporation
Hong Kong Science and Technology Parks Corporation (HKSTP) has for over 20 years committed to building up Hong Kong as an international innovation and technology hub to propel success for local and global pioneers today and tomorrow. HKSTP has established a thriving I&T ecosystem that is home to two unicorns and Hong Kong’s leading R&D hub with over 12,000 research professionals and over 1,200 technology companies focused on healthtech, AI and robotics, fintech and smart city technologies.
Established in 2001, we attract and nurture talent, accelerate and commercialise innovation and technology for entrepreneurs on their journey of growth in Hong Kong, to the Greater Bay Area, Asia and beyond. Our growing innovation ecosystem is built around our key locations of Hong Kong Science Park in Shatin, InnoCentre in Kowloon Tong and three modern INNOPARKs in Tai Po, Tseung Kwan O and Yuen Long. The three INNOPARKs are realising a vision of new industrialisation for Hong Kong. The goal is sectors like advanced manufacturing, electronics and biotechnology are being reimagined for a new generation of industry.
Through our infrastructure, services, expertise and network of partnerships, HKSTP will help establish innovation and technology as a pillar of growth for Hong Kong, while reinforcing Hong Kong’s international I&T hub status as a launchpad for global growth at the heart of the GBA innovation powerhouse.
More information about HKSTP is available at www.hkstp.org.
About AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines in Oncology, Rare Diseases and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries, and its innovative medicines are used by millions of patients worldwide. For more information, please visit www.astrazeneca.com.hk.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230404005674/en/
Contact information
Media:
PRPPL Consultancy Limited
Lee Sze Wing
Tel: +852 9811 3380
Email: w.lee@prppl.com
Edelman Public Relations
Sonia Leung
Tel: +852 2837 4775
Email: Sonia.Leung@edelman.com/ Edelmanhkstppr@edelman.com
Hong Kong Science & Technology Parks Corporation
Julia Cheung
Tel: +852 2629 6891
Email: julia.cheung@hkstp.org
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
The Coca-Cola Company Names New Leader for Europe Operating Unit18.7.2025 22:00:00 EEST | Press release
The Coca-Cola Company today announced that Luisa Ortega will become president of the Europe operating unit effective Sept. 1, succeeding Nikos Koumettis, who will retire in 2026 after a 25-year career with the company. Koumettis will remain with the company through Feb. 28, 2026, as a senior advisor. He will also serve on the board of directors of Hindustan Coca-Cola Beverages Pvt. Ltd., a company-owned bottler in India. Ortega joined Coca-Cola in 2019 and currently serves as president of the Africa operating unit. In this role, she leads a complex business that operates across 54 markets. Koumettis has led the Europe operating unit since it was created in 2021. “Luisa has done an outstanding job leading our African business, where our system has continued to make major investments to serve growing markets on the continent,” said Henrique Braun, Executive Vice President and Chief Operating Officer of The Coca-Cola Company. “As head of Europe, she will bring great international experien
NFL Running Back Derrick Henry Joins Amazfit as Athlete Ambassador18.7.2025 16:00:00 EEST | Press release
Amazfit, a leading global smart wearables brand owned by Zepp Health (NYSE: ZEPP), announced Baltimore Ravens running back Derrick Henry as the newest elite athlete to join its growing roster of ambassadors. Known for his rare combination of speed and strength, Henry will utilize Amazfit wearables to power every phase of his training, recovery and sleep as he prepares for his 10th NFL season. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250718322498/en/ Derrick Henry is the newest elite athlete to join Amazfit's growing roster of ambassadors. As one of the most prolific running backs of his generation, Henry has amassed an impressive array of accolades during his career, including NFL Offensive Player of the Year, two rushing titles, and five Pro Bowl selections. With Amazfit as his official smart wearable partner, the former Heisman winner will integrate advanced health and fitness tracking into his training regimen and r
Qualcomm Announces Quarterly Cash Dividend18.7.2025 16:00:00 EEST | Press release
Qualcomm Incorporated (NASDAQ: QCOM) today announced a quarterly cash dividend of $0.89 per common share, payable on September 25, 2025, to stockholders of record at the close of business on September 4, 2025. About Qualcomm Qualcomm relentlessly innovates to deliver intelligent computing everywhere, helping the world tackle some of its most important challenges. Building on our 40 years of technology leadership in creating era-defining breakthroughs, we deliver a broad portfolio of solutions built with our leading-edge AI, high-performance, low-power computing, and unrivaled connectivity. Our Snapdragon® platforms power extraordinary consumer experiences, and our Qualcomm Dragonwing™ products empower businesses and industries to scale to new heights. Together with our ecosystem partners, we enable next-generation digital transformation to enrich lives, improve businesses, and advance societies. At Qualcomm, we are engineering human progress. Qualcomm Incorporated includes our licensin
MultiBank Group Confirms $MBG Token Listings on MEXC and Gate.io on TGE Day in Addition to MultiBank.io and Uniswap18.7.2025 15:34:00 EEST | Press release
MultiBank Group, the world’s largest & most regulated financial derivatives institution, is proud to announce that its highly anticipated $MBG Token will be listed on two new major global cryptocurrency exchanges — MEXC and Gate.io — on the day of its official Token Generation Event (TGE), July 22, 2025, in addition to MultiBank.io and Uniswap. The $MBG Token will go live on: MultiBank.ioGate.ioMEXCUniswap This new dual listing will allow millions of users across both exchanges to seamlessly access and trade $MBG using their existing accounts, ensuring immediate market participation at launch. The Token Generation Event (TGE) is now approaching following the successful completion of two pre-sale rounds, where MultiBank Group issued 7 million tokens in Round 1 and 3 million tokens in Round 2 — both of which sold out within minutes. Naser Taher, Chairman and Founder of MultiBank Group said “With $MBG, we’re introducing a utility token built to deliver real-world value, transparency, and
SLB Announces Second-Quarter 2025 Results18.7.2025 13:50:00 EEST | Press release
SLB (NYSE: SLB) today announced results for the second-quarter 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716727689/en/ The exterior of the SLB headquarters in Houston, Texas. Second-Quarter Results (Stated in millions, except per share amounts)Three Months EndedChangeJun. 30, 2025Mar. 31, 2025Jun. 30, 2024SequentialYear-on-yearRevenue $8,546 $8,490 $9,139 1% -6% Income before taxes - GAAP basis $1,285 $1,063 $1,421 21% -10% Income before taxes margin - GAAP basis 15.0% 12.5% 15.5% 251 bps -52 bps Net income attributable to SLB - GAAP basis $1,014 $797 $1,112 27% -9% Diluted EPS - GAAP basis $0.74 $0.58 $0.77 28% -4% Adjusted EBITDA* $2,051 $2,020 $2,288 2% -10% Adjusted EBITDA margin* 24.0% 23.8% 25.0% 21 bps -103 bps Pretax segment operating income* $1,584 $1,556 $1,854 2% -15% Pretax segment operating margin* 18.5% 18.3% 20.3% 20 bps -175 bps Net income attributable to SLB, excluding charges & credits* $1,016
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom